News
We developed a genomic classification for myeloproliferative neoplasms and multistage prognostic models for predicting outcomes in individual patients. ... (Funded by the Wellcome Trust and others.) ...
The Wellcome Trust — the world’s second largest private funder of biomedical research — named Norwegian public health official John-Arne Røttingen its new CEO.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results